MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques

Frank A. W. Verreck, Richard A. W. Vervenne, Ivanela Kondova et al. · 2009

Read MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques by Frank A. W. Verreck, Richard A. W. Vervenne, Ivanela Kondova et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005264.txt.

Description

The BCG vaccine protects against tuberculosis unevenly, so better regimens are badly needed. Verreck and colleagues tested two vaccine strategies in rhesus macaques, close stand-ins for humans, in PLOS ONE in 2009. Both aimed to improve on BCG alone.

One arm boosted BCG with a modified virus vaccine called MVA.85A. The other used a weakened tuberculosis strain missing the phoP gene. Both showed protective efficacy in the monkeys. Strong animal results like these decide which candidates earn a place in human trials. Monkeys are a costly and slow test bed, so a clear win in them is the gate a new TB vaccine must pass before it can be tried in people.

Catalog record

CREATORFrank A. W. Verreck, Richard A. W. Vervenne, Ivanela Kondova et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005264

Browse the full library · About the Tower of Babel